Proportion of patients achieving a clinically relevant improvement (≥4 point increase) in SLE Responder Index-4 (SRI-4) at 52 weeks
⚠ No ClinicalTrials.gov registry ID found for this program. This trial was announced but no registered study has been identified. CelluTarget flags this distinction rather than treating announced and registered trials as equivalent.